The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

US Senator Todd Young eager to sample just-approved sustainable AquaBounty GMO fish

| | March 29, 2019

After touring a land-based fish farm that is preparing to raise genetically engineered salmon, U.S. Senator Todd Young is ready to eat. But he’ll have to wait, even though these are bred to grow faster than conventional salmon.

 Senator Todd Young

The first AquAdvantage Salmon eggs aren’t scheduled to arrive from Canada until [April], and they won’t reach market size until the third quarter of 2020. “Can you invite me in?” Young asked. “We’ll cook one. I’ll eat the first fish.” The senator wanted to see the indoor farm after the U.S. Food and Drug Administration’s recent approval of AquAdvantage Salmon, the first bioengineered animal for human consumption.

Related article:  Viewpoint: With reasonable regulation, we can turn wild plants into food with gene editing

It has taken 20 years of effort to get government approval to produce, sell and consume AquAdvantage salmon in the U.S.

Young says it shouldn’t take another 20 years for Maynard, Mass.-based AquaBounty Technologies to obtain regulatory approval for two additional products — a faster-growing bioengineered rainbow trout and a gene-edited line of tilapia that exhibits improvement in fillet yield, growth and feed efficiency.

A coalition of environmental, consumer and other groups has filed suit claiming the FDA lacks authority to regulate bioengineered animals….

Read full, original article: Senator hungry for genetically engineered fish

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend